These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 3771151

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of contrast media on neural tissue glucose uptake in vitro.
    Ekholm SE, Morris TW, Fonte D, Marinetti GV, Simon JH, Leakey P, Prentice L.
    Invest Radiol; 1989 Feb; 24(2):145-9. PubMed ID: 2917834
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vitro models for testing the metabolic effects of myelographic contrast media.
    Morris TW, Ekholm SE, Simon JH, Marinetti GV, Harnish PP, Isaac L, Fonte D, Leakey P.
    Invest Radiol; 1988 Sep; 23 Suppl 1():S213-6. PubMed ID: 3198346
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Further support for the glucose hypothesis of metrizamide toxicity. The effect of metrizamide and glucose analogue-free contrast media on hexokinase.
    Simon JH, Ekholm SE, Morris TW, Fonte DJ.
    Invest Radiol; 1987 Feb; 22(2):137-40. PubMed ID: 3557885
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Iotrol, a new myelographic agent: 2. Comparative electroencephalographic evaluation by spectrum analysis.
    Sovak M, Ranganathan R, Kerber CW, Bickford R, Alksne JF.
    AJNR Am J Neuroradiol; 1983 Feb; 4(3):319-22. PubMed ID: 6410733
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Development of nonionic contrast media.
    Almén T.
    Invest Radiol; 1985 Feb; 20(1 Suppl):S2-9. PubMed ID: 2579043
    [Abstract] [Full Text] [Related]

  • 13. Neurotoxicity of iohexol: a new nonionic contrast medium.
    Bryan RN, Centeno RS, Hershkowitz N, Poelstra RJ, Osato MS.
    Radiology; 1982 Nov; 145(2):379-82. PubMed ID: 7134441
    [Abstract] [Full Text] [Related]

  • 14. Effect of injections of contrast media on regional uptake of (14C)-2-deoxyglucose by the rat brain.
    Cicciarello R, d'Avella D, Albiero F, Mesiti M, Rosati G, Princi P, d'Aquino S, Hayes RL.
    Brain Inj; 1990 Nov; 4(1):71-6. PubMed ID: 2297603
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Iotrol, iodixanol, and 2-deoxy-D-glucose effects on neural tissue CO2 production.
    Morris TW, Ekholm SE, Prentice L, Fonte D.
    AJNR Am J Neuroradiol; 1989 Nov; 10(5):1123-6. PubMed ID: 2505529
    [Abstract] [Full Text] [Related]

  • 17. Effects of contrast media on synaptosomal phosphatidylinositols.
    Ekholm SE, Morris TW, Marinetti GV.
    Invest Radiol; 1990 Sep; 25 Suppl 1():S84-5. PubMed ID: 2283268
    [No Abstract] [Full Text] [Related]

  • 18. Experience with low osmolar contrast media a clinical and experimental study.
    Pokorny L, Nagy E, Vadon G.
    Ann Radiol (Paris); 1989 Sep; 32(1):40-2. PubMed ID: 2742325
    [Abstract] [Full Text] [Related]

  • 19. A double-blind clinical trial of iopamidol versus metrizamide for lumbosacral myelography.
    Drayer BP, Vassallo C, Sudilovsky A, Luther JS, Wilkins RH, Allen S, Bates M.
    J Neurosurg; 1983 Apr; 58(4):531-7. PubMed ID: 6338167
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.